Platelet monoamine oxidase B activity in "de novo" and l-dopa treated parkinsonian patients and controls.

doi:10.1017/s0317167100034090

Back to search

Article

Platelet monoamine oxidase B activity in "de novo" and l-dopa treated parkinsonian patients and controls.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques - 1 Aug 1998

Kuhn W, Müller T, Gerstner A, Winkel R, Goetz M E

Abstract excerpt

OBJECTIVE: Previous studies demonstrated controversial results regarding monoamine oxidase B (MAO-B) activity in platelets in the periphery in parkinsonian patients (PD). SUBJECTS AND METHODS: Therefore we determined platelet MAO-B activity in three age- and sex-matched groups of 17 untreated, so...

Topics

Aged
Aged, 80 and over
Antiparkinson Agents
Blood Platelets
Female
Humans
Levodopa
Male
Middle Aged
Monoamine Oxidase
Parkinson Disease
Phenotype

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.